Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study (Q34117775)

31 July 2017

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study (English)

1 reference

methicillin-resistant Staphylococcus aureus

31 July 2017

0 references

vancomycin

1 reference

based on heuristic

inferred from title

sulfamethoxazole/trimethoprim

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

7

Leonard Leibovici

1 reference

31 July 2017

2

Mical Paul

1 reference

31 July 2017

1

Elad Goldberg

1 reference

31 July 2017

8

Jihad Bishara

1 reference

31 July 2017

4

Zmira Samra

1 reference

31 July 2017

6

Rawi Hazzan

1 reference

31 July 2017

Olga Talker

3

1 reference

PubMed ID

20507860

31 July 2017

Maria Raskin

series ordinal

5

1 reference

PubMed ID

20507860

31 July 2017

language of work or name

English

0 references

publication date

27 May 2010

1 reference

Journal of Antimicrobial Chemotherapy

31 July 2017

1 reference

31 July 2017

65

1 reference

31 July 2017

8

1 reference

31 July 2017

1779-1783

1 reference

The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database

31 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Co-trimoxazole–Sensitive, Methicillin-ResistantStaphylococcus aureus, Israel, 1988–1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Trimethoprim-sulphamethoxazole treatment in staphylococcal endocarditis and gram-negative septicemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Bacterial endocarditis over prosthetic valves treated with trimethoprim-sulphamethoxazole combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Trimethoprim-sulfamethoxazole treatment of multiantibiotic-resistant staphylococcal endocarditis and meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infect

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ179

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ179

1 reference

31 July 2017

1 reference

PubMed ID

20507860